Adam Chamberlin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adam Chamberlin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Bruce J. Aronow
Division of Biomedical Informatics, and
1 shared publicationEmily M. Stucke
Division of Allergy and Immunology and
1 shared publicationJohn B. Harley
Center for Autoimmune Genomics and Etiology, CCHMC, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
1 shared publicationJoseph D. Sherrill
Division of Allergy and Immunology and
1 shared publication- Juan Pablo Abonia
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
1 shared publication Kenneth M. Kaufman
Center for Autoimmune Genomics and Etiology, CCHMC, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
1 shared publication
Latest Publications
- Open Access
- 14 April 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (5) , 984-992
Structural biology in variant interpretation: Perspectives and practices from two studies
- 14 April 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (5) , 984-992
Open AccessStructural biology in variant interpretation: Perspectives and practices from two studies
- 19 April 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (8)
Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is an allergic inflammatory esophageal disorder with a complex underlying genetic etiology often associated with other comorbidities. Using whole-exome sequencing (WES) of 63 patients with EoE and 60 unaffected family members and family-based trio analysis, we sought to uncover rare coding variants. WES analysis identified 5 rare, damaging variants in dehydrogenase E1 and transketolase domain–containing 1 ( DHTKD1 ). Rare variant burden analysis revealed an overabundance of putative, potentially damaging DHTKD1 mutations in EoE ( P = 0.01). Interestingly, we also identified 7 variants in the DHTKD1 homolog oxoglutarate dehydrogenase-like ( OGDHL ). Using shRNA-transduced esophageal epithelial cells and/or patient fibroblasts, we further showed that disruption of normal DHTKD1 or OGDHL expression blunts mitochondrial function. Finally, we demonstrated that the loss of DHTKD1 expression increased ROS production and induced the expression of viperin, a gene previously shown to be involved in production of Th2 cytokines in T cells. Viperin had increased expression in esophageal biopsies of EoE patients compared with control individuals and was upregulated by IL-13 in esophageal epithelial cells. These data identify a series of rare genetic variants implicating DHTKD1 and OGDHL in the genetic etiology of EoE and underscore a potential pathogenic role for mitochondrial dysfunction in EoE.
- 19 April 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (8)
Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is an allergic inflammatory esophageal disorder with a complex underlying genetic etiology often associated with other comorbidities. Using whole-exome sequencing (WES) of 63 patients with EoE and 60 unaffected family members and family-based trio analysis, we sought to uncover rare coding variants. WES analysis identified 5 rare, damaging variants in dehydrogenase E1 and transketolase domain–containing 1 ( DHTKD1 ). Rare variant burden analysis revealed an overabundance of putative, potentially damaging DHTKD1 mutations in EoE ( P = 0.01). Interestingly, we also identified 7 variants in the DHTKD1 homolog oxoglutarate dehydrogenase-like ( OGDHL ). Using shRNA-transduced esophageal epithelial cells and/or patient fibroblasts, we further showed that disruption of normal DHTKD1 or OGDHL expression blunts mitochondrial function. Finally, we demonstrated that the loss of DHTKD1 expression increased ROS production and induced the expression of viperin, a gene previously shown to be involved in production of Th2 cytokines in T cells. Viperin had increased expression in esophageal biopsies of EoE patients compared with control individuals and was upregulated by IL-13 in esophageal epithelial cells. These data identify a series of rare genetic variants implicating DHTKD1 and OGDHL in the genetic etiology of EoE and underscore a potential pathogenic role for mitochondrial dysfunction in EoE.